Oxford begins vaccination tests for the child in the stem pandemic stage

Sign up here for our daily coronavirus newsletter on what you need to know and subscribe to our Covid-19 podcast for the latest news and reviews.

The University of Oxford will begin testing the Covid-19 vaccine with which it was developed AstraZeneca Plc for children, a potential key step in ending the global pandemic.

The Oxford trial intends to enroll 300 children decrepit 6-17, the university said in a statement on Saturday. The first vaccinations will take place this month, with up to 240 children receiving the coronavirus vaccine, and the rest a meningitis vaccine, which should produce similar side effects. Astra in the US expects a larger trial with thousands of children to take place later.

The Phase II study will take place in Oxford and three UK cities – London, Southampton and Bristol – and will assess the safety and immune responses of children. Investigators will test the blow on the children decrepit Between 12 and 17 years before moving to the younger age group, with the initial dates expected by the summer, said Andrew Pollard, the trial’s lead investigator, in a Bloomberg interview.

The study will look at two dosing regimens one month and three months apart, Pollard said.

.Source